investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Identifying Cytoprotective Responses Triggered Following Initial Exposure to Targeted Therapy: Defining Improved Treatment Strategies for Patients with HER-2 Positive Breast Cancer
Marcel Bally
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Marcel Bally
BC Cancer Agency
Vancouver, Canada
Related projects
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast
Shoukat Dedhar
Development of therapeutic antibodies targeting carbonic anhydrase IX (CAIX)
Breast
Michael C Ostrowski
Genetic Analysis of the Breast Tumor Microenvironment
Breast
Xiaojiang Cui
The Role of FOXC1 in Basal-Like Breast Cancer
Breast
Susan L Mooberry
Taccalonolides: Mechanisms of Action and Cellular Resistance
Breast
Samuel Aparicio
PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance
Breast
Brad Nelson
Toward personalized immunotherapy: identifying tumour-specific factors that dictate the response of spontaneous mammary cancers to T cells
Breast
Lalage Wakefield
Development of TGF-beta antagonists for cancer therapy
Breast
Mien-Chie Hung
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
Breast